Vanda Pharmaceuticals gets FDA orphan drug status for VPO-227 in cholera

Vanda Pharmaceuticals has secured orphan drug designation for VPO-227 from the US Food and Drug Administration (FDA) for the treatment of cholera. According to the ... Read More